Publications, Pharmaceutical

Investigation of Powder Blend Uniformity and Deposition in a Nasal Cast Using a Unit Dose Nasal Device

Interest is increasing in the use of powder formulations for nasal deposition for pain relief, disorders of the central nervous systems and vaccination. This article describes an experimental study of the deposition behavior of different blends of sumatriptan, a drug used for the treatment of migraine, with a unit dose nasal device. Blends were formulated using different lactose grades, with and without magnesium stearate, and delivered to a validated nasal cast (use courtesy of Aptar Pharma/DTF/Univ. of Tours) using a proprietary unit dose nasal device from Aptar Pharma. The results show that despite differences in cohesivity successful deposition was achieved with all model formulations at target sites such as the turbinates and olfactory region. The results demonstrate the potential utility of the unit dose nasal device.

Download Publication
1 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

6 Nov 2023

Nasal Inhalation Testing: IPAC-RS Droplet Size Analysis

Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Read More
13 Oct 2023

Nasal Drug Delivery: In Vitro Anatomical Models

Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
4 Aug 2023

Aptar Pharma Discusses Intranasal Drug Delivery with PharmTech

Podcasts, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
3 Jul 2023

Nasal Spray Orientation & Sumatriptan Exposure using PK Modelling

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3 22
Back To Top